To gain further insight into tumor infiltration into the vessel-like structures, we performed IHC staining using CD31, a blood vessel endothelial cell marker (Fig. 2F and G), and LYVE1, a lymphatic endothelial cell marker (Fig. 2J and K). The gene discussed is LYVE1; the disease is neoplasm.